MENU
+Compare
PTGX
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$38.75
Change
+$0.26 (+0.68%)
Capitalization
2.31B

PTGX Protagonist Therapeutics Forecast, Technical & Fundamental Analysis

a developer of disulfide-rich peptides

Industry Biotechnology
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for PTGX with price predictions
Feb 20, 2025

PTGX sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for PTGX moved below the 200-day moving average on February 14, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PTGX as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PTGX broke above its upper Bollinger Band on January 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PTGX entered a downward trend on January 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where PTGX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PTGX just turned positive on January 21, 2025. Looking at past instances where PTGX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PTGX advanced for three days, in of 311 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PTGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.312) is normal, around the industry mean (12.644). P/E Ratio (9.151) is within average values for comparable stocks, (84.748). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.591). PTGX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (5.797) is also within normal values, averaging (254.739).

View a ticker or compare two or three
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PTGX is expected to report earnings to fall 136.06% to 19 cents per share on March 18

Protagonist Therapeutics PTGX Stock Earnings Reports
Q4'24
Est.
$0.19
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.10
Q1'24
Beat
by $2.07
Q4'23
Beat
by $0.39
The last earnings report on November 08 showed earnings per share of -54 cents, beating the estimate of -57 cents. With 659.60K shares outstanding, the current market capitalization sits at 2.31B.
A.I. Advisor
published General Information

General Information

a developer of disulfide-rich peptides

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSIMX20.91N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps Instl
EKSYX6.01N/A
N/A
Allspring Diversified Income Bldr Inst
VMGRX28.64N/A
N/A
Vanguard Mid Cap Growth Inv
GGCPX13.28N/A
N/A
Goldman Sachs International T/M Eq P
GMAEX23.20N/A
N/A
GMO Quality Cyclicals VI

PTGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with ZYME. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
-0.10%
ZYME - PTGX
40%
Loosely correlated
-5.40%
ACLX - PTGX
38%
Loosely correlated
+3.67%
SLNO - PTGX
38%
Loosely correlated
-0.13%
ETNB - PTGX
38%
Loosely correlated
-3.01%
REPL - PTGX
38%
Loosely correlated
+3.85%
More